Transformational performance set to continue Paris, France and Camberley, UK – 17 September 2020 – Novacyt (ALTERNEXT: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces its unaudited results for the six months ended 30 June 2020 and provides an update on its growth strategy. http://novacyt.com/wp-content/uploads/2020/09/Novacyt-Interim-Results-to-June-2020-17.09.20-ENGLISH.pdf
Visit PageCategory: Uncategorized
Résultats du premier semestre 2020
La dynamique du Groupe va se poursuivre et continuer de le transformer Paris, France et Camberley, Royaume-Uni – 17 septembre 2020 – Novacyt (ALTERNEXT : ALNOV ; AIM : NCYT), spécialiste mondial du diagnostic clinique, publie ses résultats non audités pour le semestre clos le 30 juin 2020 et fait le point sur sa stratégie
Visit PageAppointment of Joint Broker
Paris, France and Camberley, UK – 16 September 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, is pleased to announce the appointment of Numis Securities Limited as Joint Broker to the Company with immediate effect. http://novacyt.com/wp-content/uploads/2020/09/Novacyt-Appointment-of-Joint-Broker.pdf
Visit Page